These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6604560)

  • 1. Etomidate inhibits prolactin release but not through a dopaminergic mechanism.
    Preziosi P; Cerrito F; Vacca M
    Brain Res; 1983 Jul; 271(2):379-85. PubMed ID: 6604560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by lithium of dopamine receptors in rat prolactin release.
    Tanimoto K; Maeda K; Chihara K
    Brain Res; 1981 Nov; 223(2):335-42. PubMed ID: 6269703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of etomidate enantiomers on CRH-ACTH and prolactin release.
    Vacca M; Cerrito F; Preziosi P
    Arch Int Pharmacodyn Ther; 1983 Jun; 263(2):328-30. PubMed ID: 6309110
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
    Bero LA; Kuhn CM
    J Pharmacol Exp Ther; 1987 Mar; 240(3):825-30. PubMed ID: 3031276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin-lowering ability of (+/-)-idazoxan may be linked to a central noradrenergic-serotonergic interplay.
    Preziosi P; Martire M; Navarra P; Pistritto G; Vacca M
    J Pharmacol Exp Ther; 1989 Apr; 249(1):256-63. PubMed ID: 2565391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of prolactin secretion by benzodiazepines in vivo.
    Grandison L
    Neuroendocrinology; 1982; 34(5):369-73. PubMed ID: 6979001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of plasma prolactin in the rat by amantadine.
    Fayez M; Ahmed HH; Quadri SK
    Life Sci; 1985 Nov; 37(20):1877-80. PubMed ID: 3877233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between dopaminergic control of pituitary lactotroph function and deceleration of age-related changes in serum prolactin of diet-restricted rats.
    Atterwill CK; Brown CG; Conybeare G; Holland CW; Jones CA
    Food Chem Toxicol; 1989 Feb; 27(2):97-103. PubMed ID: 2714721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenohypophysial dopamine content and prolactin secretion in the aged male and female rat.
    Demarest KT; Moore KE; Riegle GD
    Endocrinology; 1985 Apr; 116(4):1316-23. PubMed ID: 3971917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of sex steroids and prolactin on haloperidol-induced catalepsy.
    Nicoletti F; Ferrara N; Patti F; Viglianesi M; Rampello L; Bianchi A; Reggio A; Scapagnini U
    Brain Res; 1983 Nov; 279(1-2):352-8. PubMed ID: 6315179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraventricular injection of neurotensin reduces dopamine D2 agonist binding in rat forebrain and intermediate lobe of the pituitary gland. Relationship to serum hormone levels and nerve terminal coexistence.
    von Euler G; Meister B; Hökfelt T; Eneroth P; Fuxe K
    Brain Res; 1990 Oct; 531(1-2):253-62. PubMed ID: 1981163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is inhibition of dopamine uptake relevant to the hypnotic action of i.v. anaesthetics?
    Keita H; Lecharny JB; Henzel D; Desmonts JM; Mantz J
    Br J Anaesth; 1996 Aug; 77(2):254-6. PubMed ID: 8881636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histofluorescence studies of the effect of AOAA and etomidate on catecholamine terminals. Possible GABA-NA interaction in the cerebellar cortex.
    Smiałowska M
    Folia Histochem Cytochem (Krakow); 1980; 18(1):13-21. PubMed ID: 7380352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic treatment with SCH 23390 and haloperidol: effects on dopaminergic and serotonergic mechanisms in rat brain.
    Lappalainen J; Hietala J; Koulu M; Seppälä T; Sjöholm B; Syvälahti E
    J Pharmacol Exp Ther; 1990 Feb; 252(2):845-52. PubMed ID: 2179533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined effect of quipazine and haloperidol on plasma prolactin release.
    Feigenbaum J; Yanai J; Klawans HL; Chatterton R
    Int J Neurosci; 1983; 18(1-2):37-40. PubMed ID: 6840980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical studies on quinelorane, a potent and highly selective D2-dopaminergic agonist.
    Foreman MM; Fuller RW; Hynes MD; Gidda JS; Nichols CL; Schaus JM; Kornfeld EC; Clemens JA
    J Pharmacol Exp Ther; 1989 Jul; 250(1):227-35. PubMed ID: 2526214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin release and tuberoinfundibular dopaminergic neuronal activity following single and double injections of morphine.
    Callahan P; Grandison L; Rabii J
    Brain Res; 1986 Aug; 381(1):106-12. PubMed ID: 3489504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A D-2 dopaminergic agonist stimulates secretion of anterior pituitary immunoreactive beta-endorphin in rats.
    Farah JM; Mueller GP
    Neuroendocrinology; 1989 Jul; 50(1):26-32. PubMed ID: 2569171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A developmental study of adenohypophyseal dopaminergic receptors and of haloperidol-induced prolactin release in rats.
    Becú de Villalobos D; Vacas MI; Cardinali DP; Libertun C
    Brain Res; 1984 Feb; 314(2):167-71. PubMed ID: 6423213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial characterization of a neurotransmitter pathway regulating the in vivo release of prolactin.
    Flores CM; Hulihan-Giblin BA; Hornby PJ; Lumpkin MD; Kellar KJ
    Neuroendocrinology; 1992 May; 55(5):519-28. PubMed ID: 1350068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.